(Q62618489)

English

Daclizumab induction and maintenance steroid-free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allografts

scientific article published on 01 August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Daclizumab induction and maintenance steroid-free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allografts (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

immunosuppression

1 reference

based on heuristic

inferred from title

Valentín Cuervas-Mons

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Joan Figueras

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Martin Prieto

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Angel Bernardos

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Antoni Rimola

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Jorge Ortiz de Urbina

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Manuel de la Mata

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Francisco Suárez

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 August 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Transplant International

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

641-648

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Steroid withdrawal in liver transplantation: benefits, risks, and unanswered questions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Corticosteroid withdrawal after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Liver transplantation using sirolimus and minimal corticosteroids (3-day taper).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Early cyclosporine monotherapy in liver transplantation: a 5-year follow-up of a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Steroid withdrawal at day 14 after liver transplantation: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Steroid-free immunosuppression during and after liver transplantation--a 3-yr follow-up report.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

A humanized antibody that binds to the interleukin 2 receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Safety and risk of using pediatric donor livers in adult liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Long-term safety, tolerability and efficacy of daclizumab (Zenapax) in a two-dose regimen in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Two-dose daclizumab induction therapy in 209 liver transplants: a single-center analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Liver transplant induction trial of daclizumab to spare calcineurin inhibition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Single-dose daclizumab induction therapy in patients with liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Daclizumab induction therapy in combination with tacrolimus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Staggered immunosuppression with the interleukin-2 receptor antagonist daclizumab combined with tacrolimus, prednisolone, and mycophenolate mofetil after orthotopic liver transplantation: a pilot efficacy and safety study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Banff schema for grading liver allograft rejection: an international consensus document

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

A randomised trial comparing the efficacy and safety of tacrolimus with microemulsified cyclosporine after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Cardiovascular morbidity and mortality after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Osteoporosis in liver diseases and after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Osteoporosis after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00326.X

21 January 2018

Identifiers

10.1111/J.1432-2277.2006.00326.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16827681%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q62618489&oldid=2127523530"